These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8549342)
1. Release of pefloxacin bonded on catheters after intraperitoneal implantation in mice. Carsenti-Etesse H; Forget B; Bensoussan M; Bensoussan F; Dellamonica P Drugs; 1995; 49 Suppl 2():304-6. PubMed ID: 8549342 [No Abstract] [Full Text] [Related]
2. [Pharmacokinetic basis for the use of pefloxacin in severe forms of infectious-inflammatory diseases]. Navashin PS; Smirnova LB Antibiot Khimioter; 1998; 43(12):30-8. PubMed ID: 10079873 [No Abstract] [Full Text] [Related]
3. [Pefloxacin (Abactal): role in modern therapy of bacterial infections]. Fomina IP; Smirnova LB Antibiot Khimioter; 2000; 45(8):42-7. PubMed ID: 10989724 [No Abstract] [Full Text] [Related]
4. Efficacy of subinhibitory concentration of pefloxacin in preventing experimental Staphylococcus aureus foreign body infection in mice. Carsenti-Etesse H; Entenza J; Durant J; Pradier C; Mondain V; Bernard E; Dellamonica P Drugs Exp Clin Res; 1992; 18(10):415-22. PubMed ID: 1306153 [TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. Kanellakopoulou K; Galanakis N; Giamarellos-Bourboulis EJ; Rifiotis C; Papakostas K; Andreopoulos A; Dounis E; Karagianakos P; Giamarellou H J Antimicrob Chemother; 2000 Aug; 46(2):311-4. PubMed ID: 10933660 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury]. Makarov GF; Budagov RS; Moiseeva LA; Boldueva NG Antibiot Khimioter; 1995 Aug; 40(8):36-9. PubMed ID: 8713436 [TBL] [Abstract][Full Text] [Related]
7. [Pefloxacin (Abaktal)--efficacy in treating severe infections, optimization of treatment based on pharmacokinetic and pharmacodynamic parameters]. Budanov SV; Vasil'ev AN; Smirnov LB Antibiot Khimioter; 2002; 47(12):31-6. PubMed ID: 12728632 [No Abstract] [Full Text] [Related]
8. Effect of subinhibitory concentrations of pefloxacin in infection in mice due to susceptible or resistant strains. Carsenti-Etesse H; Bensoussan M; Bensoussan F; Durant J; Pradier C; Mondain V; Bernard E; Dellamonica P Drugs; 1995; 49 Suppl 2():276-8. PubMed ID: 8549331 [No Abstract] [Full Text] [Related]
10. Efficacy of pefloxacin in the treatment of postoperative sepsis in gynaecology. Arowojolu AO; Bakare RA; Oni AA; Ayodele AE; Kayode OO Afr J Med Med Sci; 1999; 28(3-4):151-3. PubMed ID: 11205820 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravenously administered pefloxacin in the prostate; perspectives for its application in surgical prophylaxis. Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Stinios I; Chrisofos M; Giannopoulou M; Giamarellou H Int J Antimicrob Agents; 2001 Mar; 17(3):221-4. PubMed ID: 11282268 [TBL] [Abstract][Full Text] [Related]
20. Pefloxacin penetration into human necrotic pancreatic tissue. Bertazzoni Minelli E; Benini A; Muner A; Bassi C; Abbas H; Pederzoli P J Antimicrob Chemother; 1996 Aug; 38(2):237-43. PubMed ID: 8877537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]